Amarin Corporation
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 55 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 64 % · cci-v1
8 active sensors·1 observation·0 historical changes·0 structured events·historical coverage 81 %·observed since 2026-09-13
Compare Amarin Corporation with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies
